Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Windlas Biotech Financial Results

Windlas Biotech approved audited FY26 financial results and recommended a Rs. 6.30 per share dividend. The company reported unmodified audit opinions for both standalone and consolidated statements.

Key figures
Value₹0.63 Cr
Source

BSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Windlas Biotech Ltd: key numbers

Share price
₹888.70
Market cap
₹1,865 Cr
Revenue (annual)
₹904.1 Cr
Net profit (annual)
₹66.44 Cr
P/E (TTM)
28.1×Sector 46.1×
Promoter holding
63.31%+0.00% QoQ
FII holding
2.09%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Windlas Biotech Ltd

All →

Other financial results announcements

All →